Home › Compare › PKBO vs NNN

PKBO vs NNN: Dividend Comparison 2026

PKBO yields 8888.89% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PKBO wins by $17290949737713800.00M in total portfolio value
10 years
PKBO
PKBO
● Live price
8888.89%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$17290949737713800.00M
Annual income
$16,916,578,202,775,594,000,000.00
Full PKBO calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — PKBO vs NNN

📍 PKBO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKBONNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKBO + NNN cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PKBO pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKBO
Annual income on $10K today (after 15% tax)
$755,555.56/yr
After 10yr DRIP, annual income (after tax)
$14,379,091,472,359,256,000,000.00/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, PKBO beats the other by $14,379,091,472,359,256,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKBO + NNN for your $10,000?

PKBO: 50%NNN: 50%
100% NNN50/50100% PKBO
Portfolio after 10yr
$8645474868856900.00M
Annual income
$8,458,289,101,387,797,000,000.00/yr
Blended yield
97.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

PKBO
No analyst data
Altman Z
13837.7
Piotroski
4/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKBO buys
0
NNN buys
0
No recent congressional trades found for PKBO or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKBONNN
Forward yield8888.89% ✓5.66%
Annual dividend / share$2.00$2.38 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6% ✓
Portfolio after 10y$17290949737713800.00M ✓$25.5K
Annual income after 10y$16,916,578,202,775,594,000,000.00 ✓$2,622.67
Total dividends collected$17265985963886318.00M ✓$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: PKBO vs NNN ($10,000, DRIP)

YearPKBO PortfolioPKBO Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$899,589$888,888.89$10,735$614.96+$888.9K → PKBO
2$75,694,763$74,732,202.61$11,572$708.43+$75.68M → PKBO
3$5,957,858,933$5,876,865,536.53$12,531$819.53+$5957.85M → PKBO
4$438,676,028,838$432,301,119,780.33$13,633$952.29+$438676.02M → PKBO
5$30,217,280,421,144$29,747,897,070,286.80$14,909$1,111.84+$30217280.41M → PKBO
6$1,947,399,451,993,550$1,915,066,961,942,926.00$16,392$1,304.77+$1947399451.98M → PKBO
7$117,429,004,658,116,600$115,345,287,244,483,520.00$18,129$1,539.52+$117429004658.10M → PKBO
8$6,625,994,131,926,989,000$6,500,345,096,942,805,000.00$20,173$1,827.08+$6625994131926.97M → PKBO
9$349,879,939,194,586,330,000$342,790,125,473,424,500,000.00$22,597$2,181.81+$349879939194586.31M → PKBO
10$17,290,949,737,713,800,000,000$16,916,578,202,775,594,000,000.00$25,491$2,622.67+$17290949737713800.00M → PKBO

PKBO vs NNN: Complete Analysis 2026

PKBO — Stock

Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.

Full PKBO Calculator →

NNN — REIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this PKBO vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKBO vs SCHDPKBO vs JEPIPKBO vs OPKBO vs KOPKBO vs MAINPKBO vs ADCPKBO vs EPRTPKBO vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.